Hypertension: Comprehensive Management and Emerging Trends
A Six-Hour Interprofessional Symposium for Healthcare Workers
Saturday, April 18
8:45 am – 4:30 pm (ET)
Cost:
- Eligible 1199SEIU members: No out-of-pocket costs
- All other participants: $150
Live Webcast (Internet)
The deadline to register for this event is noon, Friday, April 17.
Program Moderator
Omar Al Dhaybi, MD, MS, FASN
Program and Learning Objectives
8:45 am — Participants Log in
9:20 am — Welcome and Introductory Remarks
9:30 am — Hypertension in 2026: The Past, the Present and the Future
Presenter:
Omar Al Dhaybi, MD, MS, FASN
Descriptive Summary:
This presentation offers a comprehensive overview of hypertension, encompassing its definition and historical evolution. It will address best practices in blood pressure measurement, the systematic evaluation of the hypertensive patient and an examination of the most recent ACC/AHA 2025 hypertension guidelines. It also will explore contemporary approaches to hypertension management, informed by evidence from the most influential and relevant clinical trials.
Learning Objectives:
Upon completion, participants will be able to:
- Have an historical perspective on hypertension, encompassing the evolution of our understanding of the disease and the progressive development of antihypertensive pharmacotherapy;
- Describe the 2025 ACC/AHA Hypertension Guidelines, with an emphasis on the most clinically impactful and novel recommendations;
- Discuss the comprehensive evaluation of the hypertensive patient, including diagnostic strategies and the assessment for secondary causes of hypertension; and
- Explain the contemporary management of hypertension, integrating evidence-based therapeutic approaches and a review of the most influential clinical trials shaping current practice.
10:30 am — Resistant Hypertension: Current Insights and Evolving Therapeutic Strategies
Presenter:
Mohammed A. Rafey, MD, MS, FASH, FASN
Descriptive Summary:
This presentation will provide a framework for distinguishing true resistant hypertension from pseudo-resistance, with an emphasis on the identification of key pathophysiological drivers and secondary causes. Systematic approaches to constructing and optimizing pharmacotherapy while addressing the critical barrier of non-adherence will be discussed. Pharmacological therapies poised to reshape the future treatment landscape will be explored.
Learning Objectives:
Upon completion, participants will be able to:
- Differentiate true resistant hypertension from pseudo-resistance and identify the underlying pathophysiological drivers and secondary causes that inform treatment;
- Prescribe an optimized, evidence-based pharmacological regimen and formulate strategies to overcome common barriers such as medication non-adherence; and
- Evaluate emerging interventional and pharmacological therapies and discuss their potential role in the future treatment landscape.
11:30 am — Pharmacotherapy in Hypertension
Presenter:
Paul Leis, DO
Descriptive Summary:
This presentation will review the current guidelines for blood pressure management. It will include a discussion of the different therapeutic classes available for treatment, which medications may be preferred in certain patients and what future treatments may become available.
Learning Objectives:
Upon completion, participants will be able to:
- Outline current guidelines classifying stages of hypertension;
- Discuss different available classes of therapy;
- Explain which classes are preferred and how to choose therapies; and
- Describe potential future therapy options.
12:30 pm — Lunch Break
1:30 pm — Renal Denervation for Hypertension: One Step Backward, Three Steps Forward
Presenter:
Omar Al Dhaybi, MD, MS, FASN
Descriptive Summary:
This presentation will provide an overview of renal denervation, including the underlying rationale for the therapy and a comprehensive review of clinical evidence from randomized controlled trials. Principles of patient selection, with an emphasis on how to identify those individuals who are most likely to derive meaningful benefit from the procedure, will be explored.
Learning Objectives:
Upon completion, participants will be able to:
- Describe renal sympathetic denervation;
- Discuss outcome data from randomized controlled trials; and
- Explain work up and patient selection for renal denervation.
2:30 pm — Hypertension in the Cardiometabolic Era
Presenter:
Aleesha Shaik, MD, MPH
Descriptive Summary:
This presentation will explore hypertension within the broader context of cardiometabolic disease, highlighting mechanisms that contribute to persistent and residual cardiovascular risk even when blood pressure appears well controlled. Through a case-based and clinically practical approach, participants will learn to recognize common drivers of uncontrolled hypertension, identify patients at heightened residual risk, and apply team-based strategies to improve prevention and long-term outcomes.
Learning Objectives:
Upon completion, participants will be able to:
- Describe the relationship between hypertension and cardiometabolic disease, including the roles of insulin resistance, visceral adiposity and renal dysfunction;
- Explain why cardiovascular risk may persist despite adequate blood pressure control and identify contributing factors, such as metabolic dysfunction and atherogenic lipoproteins; and
- Apply practical, team-based strategies to improve blood pressure control and overall cardiovascular disease risk reduction, including patient counseling, medication optimization and appropriate escalation of care.
3:30 pm — The Kidney Connection Between Dietary Salt and Blood Pressure
Presenter:
Joshua Rein, DO
Descriptive Summary:
This presentation will focus on the relationship among dietary salt, hypertension and kidney health. It will include a discussion on how high dietary salt intake raises blood pressure, leading to hypertension, which then can impair kidney function, contributing to more salt-retention. It will then explore the cycle in which excess salt exacerbates hypertension and chronic kidney disease progression, while chronic kidney disease further amplifies salt-sensitive hypertension.
Learning Objectives:
Upon completion, participants will be able to:
- Discuss how chronic kidney disease can exacerbate hypertension;
- Explain how hypertension can exacerbate chronic kidney disease;
- Examine the relationship between excess dietary salt and hypertension; and
- Describe how excess dietary salt can worsen blood pressure control in people with chronic kidney disease.
4:30 pm — Program Ends
Accreditation
CASACs
An application has been submitted to the New York State Office of Alcoholism and Substance Abuse Services for six (6) clock hours.
Clinical Laboratory Practitioners
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology (ASCP) for six (6) CMLE credits. ASCP CMLE credits are acceptable for the ASCP Board of Registry Certification Maintenance Program.
Dietitians/Dietetic Technicians
An application has been submitted the Commission for Dietetic Registration (CDR) for six (6) continuing education units.
Imaging Technologists
An application has been submitted to the American Society of Radiologic Technologists (ASRT) for Category A continuing education credits. The American Registry for Diagnostic Medical Sonography (ARDMS) accepts ASRT Category A credits.
Licensed Practical Nurses/Registered Nurses/Nurse Practitioners
This course is approved by the California Board of Registered Nursing for six (6) continuing education credits.
Medical Records Coders
An application has been submitted to the American Health Information Management Association (AHIMA) for six (6) continuing education credits.
Occupational Therapists/Occupational Therapy Assistants
An application has been submitted to the New York State Occupational Therapy Association, Inc. (NYSOTA) for contact hours (NY licensees only).
Paramedics/Emergency Medical Technicians
An application has been submitted to the Regional Emergency Medical Services Council of New York City for EMS CME credits.
Pharmacists and Pharmacy Technicians
The New York State Council of Health-system Pharmacists (NYSCHP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
- Module A (AM): TBD.
- Module B (PM): TBD.
Statements of Continuing Pharmacy Education Credit are available to participants upon the conclusion of the program through survey links. Participants have 45 days from date of program to claim credits and must verify attendance at the meeting by entering the program CE code.
Physical Therapists/Physical Therapy Assistants
An application has been submitted to the New York Physical Therapy Association (NYPTA) for contact hours (NY licensees only).
Respiratory Therapists
An application has been submitted to the American Association for Respiratory Care (AARC) for six (6) continuing education credits.
Social Workers
The 1199SEIU League Training and Upgrading Fund SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers under provider #0286. Licensed NYS Social Workers are required to provide NYS license number to receive certificate of credit. This course is approved for six (6) continuing education hours.
All Other Healthcare Professionals
You will receive a general certificate of attendance. Please check with your accreditation board with respect to receiving credit for this program.
Presenters:
Omar Al Dhaybi, MD, MS, FASN
Director, AHA Comprehensive Hypertension Center, Mount Sinai Fuster Heart Hospital; Assistant Professor (Cardiology), Icahn School of Medicine at Mount Sinai, New York, NY
Mohammed A. Rafey, MD, MS, FASH, FASN
Assistant Professor of Medicine (Nephrology), Director, AHA Comprehensive Hypertension Center at the University of Chicago Medicine, University of Chicago, Chicago, IL
Paul Leis, DO
Assistant Professor of Medicine (Cardiology), Icahn School of Medicine at Mount Sinai, New York, NY
Aleesha Shaik, MD, MPH
Preventive Cardiology Advanced Fellow, Metabolism and Lipids Program, Icahn School of Medicine at Mount Sinai, New York, NY
Joshua Rein, DO
Nephrologist, Mount Sinai Union Square, New York, NY
Eligibility for 1199SEIU Members
Training and Employment Fund Members
Members must have been a part-time or full-time employee for at least one year, work at least three-fifths of a regular workweek, and work for an employer who contributes to the 1199SEIU League Training and Upgrading Fund or the 1199SEIU Greater New York Education Fund.
City of New York Education, Child and Eldercare Fund Members
Pharmacists, Dietitians, Clinical Laboratory Practitioners and LPNs must have worked with NYC Health + Hospitals or a mayoral agency for at least one year.
Registered Nurse Training and Job Security Fund members
Members must have been a part-time or full-time employee for at least one year and work for an employer who contributes to the 1199SEIU/Hospital League Health Care Industry Registered Nurse Training and Job Security Fund.
For Further Information
Email: Institute@1199Funds.org
Refund and Cancellation Policy
If you wish to cancel, you must do so at least 48 hours before the program date to avoid a penalty. To cancel, contact the 1199SEIU League Training and Upgrading Fund (TUF) by telephone, (212) 894-4390; fax, (212) 643-8795; or email, Institute@1199Funds.org. TUF reserves the right to cancel or reschedule a program in the event of insufficient enrollment or unforeseen circumstances. Participants will be notified and given the option of receiving a refund or attending the rescheduled program or an alternate program.
